Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of recombinant IRAP (unknown origin) expressed in ovalbumin expressing wild type HEK293S cells assessed as decrease in antigen-mediated IL-2 production increase in B3Z T cells pretreated with compound for 1 hr followed by washout and incubated with compound for overnight prior to B3Z T cell addition and measured after 24 hrs by sandwich ELISA assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of recombinant IRAP (unknown origin) expressed in HEK293S cells using L-AMC as substrate by flourescence assay
Assay data:29 Active, 16 Activity ≤ 1 µM, 36 Tested
Inhibition of recombinant human IRAP expressed in HEK293 cells at 100 uM using L-AMC as substrate preincubated for 30 mins followed by substrate addition measured every 3 mins for 1 hr by flourescence assay relative to control
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of recombinant human IRAP expressed in HEK293 cells using L-AMC as substrate preincubated for 30 mins followed by substrate addition measured every 3 mins for 1 hr by flourescence assay
Assay data:1 Tested
Binding affinity to recombinant full length human IRAP expressed in HEK293T cells assessed as binding free energy
Assay data:13 Tested
Binding affinity to recombinant full length human IRAP expressed in HEK293T cells using Leu-MCA as substrate
Assay data:6 Active, 7 Activity ≤ 1 µM, 8 Tested
Inhibition of recombinant full length human IRAP expressed in HEK293T cells assessed as substrate cleavage using Leu-MCA as substrate by fluorogenic assay
Assay data:6 Active, 3 Activity ≤ 1 µM, 8 Tested
Competitive inhibition of human IRAP soluble domain expressed in HEK293S GnTI(-) cells assessed as increase in Km with constant Vmax using Arg-AMC as substrate incubated for 2 hrs by fluorescence assay based Michaelis-Menten analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human IRAP soluble domain expressed in HEK293S GnTI(-) cells using Leu-AMC as substrate incubated for 2 hrs by fluorescence based assay
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of human IRAP soluble domain expressed in HEK293S GnTI(-) cells using Arg-AMC as substrate incubated for 2 hrs by fluorescence based assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Competitive inhibition of human recombinant IRAP expressed in baculovirus infected sf9 cells assessed as substrate Kcat using varying levels of L-AMC as substrate incubated for 5 to 10 mins by Michaelis-Menten analysis (Rvb = 0.10 +/- micromol/min/nmol)
Competitive inhibition of human recombinant IRAP expressed in baculovirus infected sf9 cells assessed as substrate Km using varying levels of L-AMC as substrate incubated for 5 to 10 mins by Michaelis-Menten analysis (Rvb = 27 +/- 3 uM)
Competitive inhibition of human recombinant IRAP expressed in baculovirus infected sf9 cells using L-AMC as substrate incubated for 5 to 10 mins by Michaelis-Menten analysis
Assay data:6 Active, 8 Tested
Inhibition of human recombinant IRAP expressed in baculovirus infected Sf9 cells using omniMMP fluorogenic substrate incubated for 5 to 10 mins by fluorescence spectrophotometry analysis
Assay data:4 Active, 10 Tested
Inhibition of human IRAP at <200 uM preincubated for 20 mins followed by L-leucine-7-amido-4-methylcoumarin addition by fluorescence assay
Activation of IRAP (unknown origin)-mediated Leu-AMC substrate hydrolysis after 60 mins by Rapidfire-MS analysis
Inhibition of human IRAP using L-leucine 7-amido-4-methyl coumarin substrate by microplate fluorescence reader based assay
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Genome-wide siRNA screen of genes regulating the Lipopolysaccharide-induced TNF-alpha response in human macrophages_Primary screen TNF readout
Assay data:2853 Active, 18113 Tested
SummaryRelated BioAssays by Same Project
A screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line
Assay data:2442 Active, 18052 Tested
SummaryPubMed Citation
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on